Abstract:
Aqueous protein-containing solutions, in which a protein is dissolved at a high concentration at a pH near the isoelectric point of the protein by adding an anionic polymer or a salt thereof to the solution. Pharmaceutical formulations using a physiologically active protein are prepared using this technique.
Abstract:
An image encoding control system includes an orthogonal transform encoder for carrying out orthogonal transform coding for each block which includes transform coefficients related to a plurality of blocks, each block obtained by dividing one picture of an input image signal into the plurality of blocks, a code control for controlling the transform coefficients obtained for each block so that the number of variable-length code words obtained for each block is equal to or smaller than a predetermined number of variable-length code words, a variable-length encoder for converting the transform coefficients obtained for each block into variable-length code words, and a buffer memory for temporarily storing the variable-length code words output by the variable-length encoder for each block.
Abstract:
A two-dimensional discrete cosine transform computing circuit has a transform block, formed by a multiplication unit and a Hadamard transform unit, which performs computations in a sequence of Hadamard transforms followed by multiplications in a two-dimensional discrete cosine transform, and in a sequence of multiplication followed by Hadamard transforms in an inverse two-dimensional discrete cosine transform. A memory block temporarily stores input/output data of the transform block; an input/output processing block performs pre-processing and post-processing such as cumulative addition and subtraction of input/output data of the transform block. A control block controls, when performing processing for either a two-dimensional discrete cosine transform or inverse two-dimensional discrete cosine transform, multiplications of coefficients in the transform block, read/write of the memory block, and the input/output processing block. This configuration achieves high-speed processing and a reduction in scale of the circuitry.
Abstract:
A transfer material carrying member has a copolymer and conductive particles; the copolymer has a component unit represented by the Formula (I) and a component unit represented by the Formula (II), and the component unit represented by Formula (II) is in an amount of from 0.1% by weight to 50% by weight based on the total weight of the copolymer.
Abstract:
An electrophotographic photosensitive medium has a photosensitive layer on an electroconductive base, the medium having at least one intermediate layer between the base and the photosensitive layer, the intermediate layer containing indium oxide - tin oxide solid solution (ITO) powder and a binder resin. An electrophotographic apparatus includes a photosensitive medium; a device for forming latent images; a device for developing formed latent images; and a device for transferring developed images to a transfer member.
Abstract:
The present invention discloses an image bearing member having a surface layer comprising a high-melting point polyester resin, a cured resin and an antioxidant, and an apparatus which uses the same.
Abstract:
An electrophotographic photosensitive member is characterized by comprising a charge generation layer containing at least one disazo pigment represented by the following formula [I] and a charge transport layer containing at least one hydrazone compound represented by the following formula [II]: ##STR1## wherein A is a coupler residue, B represents hydrogen, halogen, alkyl, or alkoxy, and n is an integer of 1 to 4; ##STR2## wherein R.sub.1 represents N,N-dialkyl amino, or N,N-diarylamino, or N-alkyl-N-arylamino, or alkoxy or aryloxy, each being substituted or unsubstituted; R.sub.2 and R.sub.3 each represent alkyl, aralkyl, or aryl, each being substituted or unsubstituted, or R.sub.2 and R.sub.3, together with the nitrogen atom which links them, represent nitrogen-containing heterocyclic ring; R.sub.4 represents hydrogen, or alkyl, aralkyl, or aryl, each being substituted or unsubstituted; R.sub.5 represents hydrogen, alkyl, or alkoxy; and l is 0 or 1.
Abstract:
Hydrazone compounds having the general formula ##STR1## wherein Ar is selected from the group consisting of a naphthalene ring radical, substituted naphthalene ring radicals, an anthracene ring radical, substituted anthracene ring radicals, styryl, substituted styryls, a pyridine radical, a furan ring radical and a thiophene ring radical.The hydrazone compounds can be prepared by allowing 1-methyl-1-phenylhydrazine having the formula ##STR2## to react with an aldehyde represented by the general formula Ar-CHO, wherein Ar is the same as mentioned above at a substantially equal molar ratio in an organic solvent selected from the group consisting of lower alcohols, cyclic ethers, cellosolves, N,N-dimethylforamide and acetic acid, in the presence of an acid catalyst, by heating and refluxing the reaction mixture.The hydrazone compounds are extremely useful as charge transport materials for use in electrophotographic photoconductors of the type comprising an electroconductive support material and a photosensitive layer containing a charge generation material and a charge transport material.
Abstract:
Prostanoic acid derivatives having the formula ##STR1## wherein A represents a straight or branched alkylene group having from one to 5 carbon atoms, R.sup.1 represents a straight or branched alkyl group having from 4 to 10 carbon atoms and R.sup.2 represents hydrogen atom or a straight or branched alkyl group having from one to 6 carbon atoms and pharmaceutically acceptable salts thereof.The compounds are useful as oxytocic agents and agents inhibiting the secretion of gastric acid and may be prepared by oxidizing a compound having the formula ##STR2## wherein A, R.sup.1 and R.sup.2 are the same as above, R.sup.3 and R.sup.4 are the same or different and each represents a protecting group for the hydroxyl group to give a compound having the formula ##STR3## wherein A, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are the same as above, removing the hydroxyl-protecting group from the latter compound and, if appropriate, salifying the product thus obtained.
Abstract:
New prostaglandin-like compounds, having brochodilating activity, of formula ##SPC1##(wherein A represents a direct bond or an alkylene group and R.sup.1 represents an alkyl group) and their pharmaceutically acceptable salts are prepared by oxidizing compounds of formula ##SPC2##(wherein R.sup.2 represents hydrogen or a carboxyl-protecting group, and R.sup.3 represents a hydroxyl-protecting group), removing protecting groups from the product and, when appropriate, salifying the compound obtained.